FLORIDA ATLANTIC UNIVERSITY IMAGE: RICHARD ISAACSON, M.D., DIRECTOR, ALZHEIMER’S PREVENTION CLINIC IN THE CENTER FOR BRAIN HEALTH AT FAU’S SCHMIDT COLLEGE OF MEDICINE, MEASURES A PATIENT’S PERCENTAGE OF BODY FAT AND MUSCLE MASS OVER TIME TO EVALUATE RESPONSE TO THERAPIES AND HELP REFINE EXERCISE AND NUTRITION PLANS. CREDIT: FLORIDA ATLANTIC UNIVERSITY After increasing age, the...
Free Resurgence of avian influenza virus raises concern
AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE (AAAS) With the recent outbreaks identified in Canada and the United States, H5N1 – a strain of highly pathogenic avian influenza virus (HPAIv) – is rapidly becoming a global concern. The virus has already caused widespread outbreaks throughout Asia, Africa and Europe, resulting in millions of deaths in...
A new treatment reduces inflammation in multiple sclerosis mice models
UNIVERSITAT AUTONOMA DE BARCELONA A team led by the Institut de Neurociències at the Universitat Autònoma de Barcelona (INc-UAB) managed to reduce chronic inflammation associated with multiple sclerosis in mice thanks to the administration of a type of lipid that mediates inflammation. The team found that these types of mediator substances, responsible for resolving the...
New graphite based rapid sensor chip for real-time theophylline monitoring
SHIBAURA INSTITUTE OF TECHNOLOGY IMAGE: RESEARCHERS FROM SIT, JAPAN, HAVE DESIGNED A LOW-COST SENSOR CHIP WITH GRAPHITE-BASED MOLECULARLY IMPRINTED POLYMER AS THE ELECTRODE. THIS CHIP CAN BE USED FOR DETECTING AND MONITORING THEOPHYLLINE LEVELS. CREDIT: YASUO YOSHIMI FROM SIT, JAPAN Theophylline or THO is a natural organic compound whose molecular structure is very similar to...
Corticosteroids raise the risk of hospitalization for pain crises among individuals living with sickle cell disease
AMERICAN SOCIETY OF HEMATOLOGY (WASHINGTON, April 26, 2022) — People with sickle cell disease (SCD) who were recently prescribed a corticosteroid – a medicine frequently used to treat asthma or inflammation – were found to be significantly more likely to be hospitalized for a severe pain event, according to a paper published today in the journal Blood. The...
AI may detect earliest signs of pancreatic cancer
CEDARS-SINAI MEDICAL CENTER An artificial intelligence (AI) tool developed by Cedars-Sinai investigators accurately predicted who would develop pancreatic cancer based on what their CT scan images looked like years prior to being diagnosed with the disease. The findings, which may help prevent death through early detection of one of the most challenging cancers to treat,...
Cancer cells found to repair their own membranes after attack by T cells
by Bob Yirka, Medical Xpress Credit: Science (2022). DOI: 10.1126/science.abl3855 A team of researchers from Genetch, Inc., the Howard Hughes Medical Institute and the Peter MacCallum Cancer Center, has found that cancerous tumor cells are able to survive attacks by repairing holes in their membranes caused by a protein released from T cells. In their paper published...
Wireless device to provide new options for colorectal cancer treatment
by Rachel Rose, Texas A&M University The small device is designed to enable more individualized application of light dosing and photodynamic therapy. Credit: Justin Baetge/Texas A&M Engineering For those diagnosed with colorectal cancer, surgery has been the only option that offers a solution. Unfortunately, surgery is frequently complicated by disease recurrence at the site of...
Long COVID associated with different clinical trajectories, characteristics depending on severity of initial infection
by European Society of Clinical Microbiology and Infectious Diseases Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID New research to be presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in...
Could blocking or deleting a protein help prevent common oral cancers?
by Boston University Manish V. Bais, a BU Goldman School of Dental Medicine assistant professor of translational dental medicine, has found the lysine-specific demethylase 1 protein is a potential oral cancer “druggable target,” knowledge that may one day help doctors take down tumors. Credit: Cydney Scott for Boston University Photography The most common head and...